Literature DB >> 31246748

Mapping the Affective Dimension of Embodiment With the Sensation Manikin: Validation Among Chronic Pain Patients and Modification by Mindfulness-Oriented Recovery Enhancement.

Adam W Hanley1, Eric L Garland.   

Abstract

OBJECTIVE: Mindfulness-based interventions target novel pain relief mechanisms not captured by legacy pain scales, including 1) cultivating awareness of pleasant and neutral sensations proximal to unpleasant sensations and 2) interoceptively mapping sensation location and spatial distribution.
METHODS: We created a digital sensation manikin (SM) by overlaying a human figure silhouette with a grid of 469 "sensation" pixels. A series of five research questions examined the SM's discriminant validity, construct validity, incremental validity, convergence with an objective measure of pain attentional bias, and sensitivity to a mindfulness-based psychological treatment, Mindfulness-Oriented Recovery Enhancement (MORE). A sample of opioid treated chronic pain patients (n = 108; age, 53.79 (12.94) years; female, 65%) was recruited to answer research questions 1 to 5, and a sample of healthy controls (n = 91; age, 36.47 (13.50) years; female, 55%) was recruited as the comparison group for research question 1.
RESULTS: Chronic pain patients reported significantly more unpleasant sensations than did healthy controls (p < .001, d = 1.23) and significantly fewer pleasant sensations (p = .001, d = 0.50). The SM also evidenced expected relationships with multiple measures of pain (r = 0.26-0.29) and well-being (r = -0.21 to 0.28), uniquely predicted pain interference (β = -0.18), and exhibited a significant association with pain attentional bias (r = 0.25). Finally, mindfulness-based intervention via MORE significantly increased the ratio of pleasant to unpleasant sensations reported by chronic pain patients relative to an active control condition (p = .036, d = 0.51).
CONCLUSIONS: This study supports the SM's validity and indicates that assessing both pleasant and unpleasant sensations broadens the scope of pain measurement. Although the SM would benefit from further optimization, its continued use is likely to contribute to improved assessment and treatment options for chronic pain patients.

Entities:  

Mesh:

Year:  2019        PMID: 31246748     DOI: 10.1097/PSY.0000000000000725

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  5 in total

1.  The 2019 addiction health services research conference: Insights, review, and abstracts.

Authors:  Mitchell Garets; Shayla Archer; Connie Kitchens; Gerald Cochran; Adam J Gordon
Journal:  Subst Abus       Date:  2019       Impact factor: 3.716

2.  Mindfulness-oriented recovery enhancement reduces opioid dose in primary care by strengthening autonomic regulation during meditation.

Authors:  Eric L Garland; Justin Hudak; Adam W Hanley; Yoshio Nakamura
Journal:  Am Psychol       Date:  2020-09

3.  Mindful Positive Emotion Regulation as a Treatment for Addiction: From Hedonic Pleasure to Self-Transcendent Meaning.

Authors:  Eric L Garland
Journal:  Curr Opin Behav Sci       Date:  2021-04-24

4.  Psychosocial intervention and the reward system in pain and opioid misuse: new opportunities and directions.

Authors:  Eric L Garland
Journal:  Pain       Date:  2020-12       Impact factor: 7.926

5.  The OPTIMIZE study: protocol of a pragmatic sequential multiple assessment randomized trial of nonpharmacologic treatment for chronic, nonspecific low back pain.

Authors:  Richard L Skolasky; Stephen T Wegener; Rachel V Aaron; Patti Ephraim; Gerard Brennan; Tom Greene; Elizabeth Lane; Kate Minick; Adam W Hanley; Eric L Garland; Julie M Fritz
Journal:  BMC Musculoskelet Disord       Date:  2020-05-11       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.